The legacy success of sildenafil has undeniably shaped the drug landscape. However, putting money in companies heavily dependent on biosimilars and the diminishing patent rights surrounding this flagship medication presents a notable degree of peril . While established pharma firms may still realize gains from related therapies , the net outlook fo

A thorough industry review is critical for identifying the current dynamics at play. This study delves into major elements influencing the contested arena, from developing technologies and evolving consumer preferences to regulatory hurdles and economic risks. We’ll evaluate the general outlook, including probable expansion areas, threats to exis